These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2113806)

  • 1. Relief of chronic burning pain in Fabry disease with neurotropin.
    Inagaki M; Ohno K; Ohta S; Sakuraba H; Takeshita K
    Pediatr Neurol; 1990; 6(3):211-3. PubMed ID: 2113806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of an extract from the inflamed skin of rabbits inoculated with vaccinia virus on glutamate-induced neurotoxicity in cultured neuronal cell line.
    Itoh T; Satou T; Nishida S; Tsubaki M; Hashimoto S; Ito H
    Neurol Res; 2008 May; 30(4):430-4. PubMed ID: 18241529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effects of neurotropin in a rat model of central neuropathic pain: DSP-4 induced noradrenergic lesion.
    Kudo T; Kushikata T; Kudo M; Kudo T; Hirota K
    Neurosci Lett; 2011 Sep; 503(1):20-2. PubMed ID: 21843596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of neurotropin on chronic headaches in children].
    Saito Y; Fukumura S; Saito T; Komaki H; Nakagawa E; Sugai K; Sasaki M
    No To Hattatsu; 2012 Nov; 44(6):477-81. PubMed ID: 23240530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain relief by carbamazepine in mercury poisoning.
    Karagöl U; Deda G; Kükner S; Ince E; Onal MZ
    Eur J Pediatr; 1998 Mar; 157(3):260-1. PubMed ID: 9537499
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer pain.
    O'Neill WM
    Middle East J Anaesthesiol; 1996 Feb; 13(4):373-8. PubMed ID: 8713631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative hypoxia of the extremities in Fabry disease.
    Inagaki M; Ohno K; Hisatome I; Tanaka Y; Takeshita K
    Brain Dev; 1992 Sep; 14(5):328-33. PubMed ID: 1456389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between neurotropin and mepivacaine for stellate ganglion injection.
    Nishiyama T; Matsukawa T; Yamashita K
    J Anesth; 2006; 20(3):240-2. PubMed ID: 16897249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model.
    Kawashiri T; Egashira N; Watanabe H; Ikegami Y; Hirakawa S; Mihara Y; Yano T; Ikesue H; Oishi R
    Eur J Pain; 2011 Apr; 15(4):344-50. PubMed ID: 20829082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the analgesic effect of neurotropin.
    Hata T; Kita T; Itoh E; Oyama R; Kawabata A
    Jpn J Pharmacol; 1988 Oct; 48(2):165-73. PubMed ID: 3210443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic drugs in the management of pain.
    Halpern LM
    Arch Surg; 1977 Jul; 112(7):861-9. PubMed ID: 18128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT3 and noradrenergic alpha2 receptors in spinal dorsal horn.
    Kawamura M; Ohara H; Go K; Koga Y; Ienaga K
    Life Sci; 1998; 62(24):2181-90. PubMed ID: 9627076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral methadone for the management of difficult to control pain in Fabry disease].
    Leyva Carmona M; Gómez Bueno S; Ruiz Tudela L; Aguirre Rodríguez J; Sanchez F
    An Pediatr (Engl Ed); 2018 Jan; 88(1):47-48. PubMed ID: 28094225
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined antiallodynic effect of Neurotropin® and pregabalin in rats with L5-spinal nerve ligation.
    Okazaki R; Namba H; Yoshida H; Okai H; Taguchi K; Kawamura M
    Life Sci; 2013 Mar; 92(4-5):259-65. PubMed ID: 23333830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of pain in fabry disease.
    Üçeyler N; Ganendiran S; Kramer D; Sommer C
    Clin J Pain; 2014 Oct; 30(10):915-20. PubMed ID: 24121530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotropin® relieves oxaliplatin-induced neuropathy via Gi protein-coupled receptors in the monoaminergic descending pain inhibitory system.
    Masuguchi K; Watanabe H; Kawashiri T; Ushio S; Ozawa N; Morita H; Oishi R; Egashira N
    Life Sci; 2014 Mar; 98(1):49-54. PubMed ID: 24412642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable Back Pain After Coil Embolization of Giant Veno-Venous Collaterals in a Patient With Fontan Circulation.
    Okada S; Kamada M; Nakagawa N; Ishiguchi Y; Moritoh Y; Shohi M; Okamoto K; Hasegawa S; Ohga S
    Int Heart J; 2017 Apr; 58(2):298-301. PubMed ID: 28320993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selection of drugs suitable for the treatment of intractable chronic pain patients by using drug challenge tests].
    Hanaoka K; Arita H; Nagase M; Ide Y; Tagami M; Hayashida M
    Brain Nerve; 2008 May; 60(5):519-25. PubMed ID: 18516974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of ketamine for intractable burning pain of HTLV-1-associated myelopathy.
    Kubota T; Miyata A
    J Pain Symptom Manage; 2005 Nov; 30(5):397-9. PubMed ID: 16310613
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of intractable pain.
    Lipton S
    Practitioner; 1975 Oct; 215(1288):461-7. PubMed ID: 662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.